Related Experiment Videos
CpG dinucleotides are mutation hot spots in phenylketonuria
V Abadie1, S Lyonnet, N Maurin
1Unité de Recherches de Génétique Médicale, INSERM U-12, Hôpital des Enfants-Malades, Paris, France.
Genomics
|November 1, 1989
Summary
CpG doublets in the phenylalanine hydroxylase (PAH) gene may be mutation hotspots. Researchers found two novel mutations in exon 7 of PAH-deficient patients, suggesting CpG doublets are key sites for PAH gene mutations.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- The phenylalanine hydroxylase (PAH) gene is crucial for amino acid metabolism.
- Mutations in the PAH gene cause phenylketonuria (PKU), a metabolic disorder.
- CpG dinucleotides are known mutation hotspots due to 5-methylcytosine deamination.
Purpose of the Study:
- To investigate if CpG doublets in the PAH gene act as mutation hotspots.
- To identify novel mutations in the seventh exon of the PAH gene in patients with PAH deficiencies.
Main Methods:
- Systematic sequence analysis of exon 7 of the PAH gene.
- Analysis of 20 unrelated PAH-deficient kindreds of Mediterranean ancestry.
- Restriction fragment length polymorphism (RFLP) analysis.
Main Results:
- Two novel missense mutations (CG to CA and CG to TG) were identified in CpG doublets within PAH exon 7.
- These mutations (codon 261 Arg→Gln and codon 252 Arg→Trp) are consistent with 5-methylcytosine deamination.
- The codon 261 mutation was associated with the frequent mutant RFLP haplotype 1, but not exclusively, indicating genotypic heterogeneity.
Conclusions:
- CpG doublets in the PAH gene are likely mutation hotspots contributing to PAH deficiencies.
- The frequent RFLP haplotype 1 at the PAH locus is genotypically diverse in Mediterranean populations.
- Further research is needed to fully characterize PAH gene mutations and their associated haplotypes.